Is now the time to snap up these 2 unloved stocks?

Harvey Jones asks whether it is time to show a little love to these two stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 250 guarantor loans lender Amigo Holdings (LSE: AMGO) is short of friends on the stock market today with the stock down almost 5% after reporting slower profit and revenue growth for the third quarter.

Bad credit

However, there were positive numbers too, with revenue up 34% to £201m over the nine months to 31 December, while adjusted profit after tax of £72m was up 37% on the previous year.

It also signed up a further 10,000 customers, while its net loan book grew 15% to £695.7m. Amigo, which floated in London last June, also made its first loans to customers in Ireland this month. Arrears don’t seem to be a problem, with 95% of its loan book either fully up to date or within 31 days overdue.

Brexit bothers

Amigo provides guarantor loans to borrowers who are unable to borrow from traditional lenders due to poor credit histories, offering borrowers with poor credit backgrounds a potential lifeline. It’s a simple business offering a single transparent mid-cost product, a guarantor backed loan at 49.9% APR with no additional charges or fees

CEO Glenn Crawford hailed another strong set of results, “delivering further growth in our customer numbers, loan book and revenue, whilst continuing to carefully manage our impairment levels”. It recently secured lower funding lines and remains confident of delivering full-year objectives, despite Brexit uncertainties.

Sub-prime investment

Investors aren’t so impressed and the stock trades at just 9.6 times forecast earnings with a PEG of 0.6. On the plus side it does offer a forecast yield of 4.1%, generously covered 2.6 times. Operating margins are an impressive 48.1%, while earnings are forecast to grow by 17% and 23% over the next couple of years. These are promising numbers especially if it can continue to keep a list of impairments, even if we do get some Brexit bumpiness.

The non-standard loans sector can be a rough business to be in, just ask investors in doorstep lender Provident Financial (LSE: PFG). By definition, businesses are lending money to people who are more likely to default than mainstream borrowers, although this also gives them the opportunity to charge dramatically higher interest rates which should more than cover the risk. Provident also sells high-interest Vanquis credit cards, payday loans and car finance through its Moneybarn brand.

Low expectations

The group has lost three-quarters of its value over the last three years following a string of profit warnings, as well as the shock departure of its chief executive Peter Crook and a scrapped dividend. In 2017, the Bradford-based group alerted investors to losses of between £80m and £120m in its home credit business this year after it changed the way it collected loans. Other issues included a £169m compensation bill and a £2m fine for mis-selling financial products.

It has continued to give investors a bumpy ride this year, plunging 20% in mid-January after warning that earnings would be at the low end of expectations.

Takeover question

Non-traditional lenders also have to cope with stiffer regulation, which saw off Wonga last year, after the Financial Conduct Authority imposed a cap on payday loan repayments.

Fund manager Neil Woodford, who owns 25% of Provident’s stock, is backing a surprise £1.3bn takeover by Non-Standard Finance but Roland Head says don’t buy into it. You might be tempted by the group’s forecast valuation of 11.4 times earnings, 5.5% yield and major turnaround potential. I’m not, though.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »

Investing Articles

The Meta share price falls 10% on weak Q2 guidance — should investors consider buying?

The Meta Platforms' share price is down 10% after the company reported Q1 earnings per share growth of 117%. Does…

Read more »

Investing Articles

This FTSE 250 defence stock looks like a hidden growth gem to me

With countries hiking defence spending as the world grows more insecure, this FTSE 250 firm has seen surging orders and…

Read more »